19-Nov-2026 11:14:24
BETA : SIGNS ALGERIA ONCOLOGY JV FOR $8.7 MN
• Board approved JVA with IMGSA Groupe SPA to incorporate JV company IMGSA Oncologie SPA in Algeria for manufacturing and marketing oncology formulations • Bet…
Latest market headlines for BETA on Terminal.
19-Nov-2026 11:14:24
• Board approved JVA with IMGSA Groupe SPA to incorporate JV company IMGSA Oncologie SPA in Algeria for manufacturing and marketing oncology formulations • Bet…
19-Nov-2026 11:12:23
• Strategic JV: Signed Joint Venture Agreement with Algeria-based IMGSA Groupe SPA to manufacture and market oncology pharmaceutical products • Investment Size…
22-Oct-2026 18:05:58
• FY27 REVENUE TARGETED ABOVE ₹535 CR • REVENUE GROWTH EXPECTED AT 20–25% ANNUALLY OVER NEXT 3–5 YEARS • EBITDA MARGIN GUIDANCE MAINTAINED AT 23–24%, WITH LONG…
22-Oct-2026 11:15:17
REVENUE UP 33% AT ₹137 CR (YOY), UP 10% (QOQ) EBITDA UP 42% AT ₹30 CR (YOY), UP 11% (QOQ) MARGINS AT 22.0% VS 20.6% (YOY), 21.8% (QOQ)
22-Oct-2026 11:14:41
• Revenue up 29.2% at ₹263.04 Cr (YOY). • Ebitda up ~30% at ₹61 Cr (YOY); Ebitda margins 23.18% v 23.08%, gross margins 56.2% v 51.35% (YOY). • Branded oncolog…
22-Sept-2026 09:01:46
• Beta Drugs received approvals for its oncology portfolio across multiple dosage forms in Azerbaijan. • The company has filed 15 oncology product dossiers for…